Private credit managers are stepping into the gap between venture equity and bank lending, structuring non-dilutive debt for defence robotics companies scaling production. The EIF EUR 30M cornerstone in Sienna Hephaistos marks a structural shift in defence manufacturing capitalisation.
The U.S. Army's DEVCOM CBC is developing deployable bioprinting stations that could print skin grafts on the frontline — a technology bridging battlefield trauma care and regenerative biomanufacturing.
AI-powered autonomous satellite operations are moving from experimental demonstrations to deployed systems. Slingshot Aerospace’s $69.2M Space Force MENTAT contract, onboard AI inference at Planet Labs, and a growing commercial layer are driving the shift.
CME Group and Silicon Data are launching the first compute futures market. GPU pricing benchmarks from three independent providers are turning compute into a financeable asset class.
Scindo raises £4 million for AI-powered enzyme discovery, joining a wave of startups using machine learning to engineer enzymes for sustainable industrial chemistry.
AI-native antibody design platforms are approaching clinical validation in 2026. BigHat Biosciences leads with $105M raised, AbbVie and Eli Lilly partnerships, and a GI cancer ADC nearing trials.
39 defence-tech companies are pre-IPO. Pension funds and sovereign wealth are buying in. The sector is transitioning from niche venture capital to institutional asset class — here is what that means for investors.
Tomorrow.io raised $210 million for DeepSky, the first AI-native satellite weather network, closing an observation gap that limits every AI weather model in operation today. Analysis of the emerging market for orbital weather intelligence and dual-use space infrastructure.
Get daily updates on the technologies and investment opportunities shaping the next decade — from AI infrastructure and autonomous systems to biotech, space, and defence. Curated analysis, no noise.
